Suppr超能文献

腔内修复加烟囱技术治疗肾下型腹主动脉瘤:单中心经验。

Endovascular repair with chimney technique for juxtarenal aortic aneurysm: a single center experience.

机构信息

Department of Vascular Surgery, General Hospital of People's Liberation Army, Beijing, China.

Department of Vascular Surgery, General Hospital of People's Liberation Army, Beijing, China.

出版信息

Eur J Vasc Endovasc Surg. 2015 Mar;49(3):271-6. doi: 10.1016/j.ejvs.2014.11.012. Epub 2015 Jan 24.

Abstract

OBJECTIVE

Chimney endovascular aneurysm repair (Ch-EVAR) is a cheap and immediately available method for treatment of juxtarenal aortic aneurysms (JRAAs). The aim of this study was to report experiences and results with balloon expandable stent (BES) for Ch-EVAR.

METHODS

From January 2008 to June 2013 (mean time, 26 ± 13 months), 42 patients who underwent Ch-EVAR were retrospectively reviewed. All patients were thought to be at high risk for open surgery and were unsuitable (because of financial issues and fear of delays) for fenestrated endovascular aneurysm repair (FEVAR).

RESULTS

42 patients (35 males; mean age 71 ± 7 years) underwent chimney procedures for 56 renal arteries with 70 BESs (59 hippocampus and 11 genesis). Median follow up was 26 months (range 6-64 months). Primary technical success was 100%. Thirty day mortality was 0%. Completion angiography showed that eight cases (19%) had a type I endoleak. The 6 month follow up CT scans demonstrated three cases with complete regression of endoleak, two cases without aneurysmal growth, and three cases with an increase in aneurysmal diameter of less than 10 mm. Three patients had contrast induced nephropathy (CIN) after Ch-EVAR, two of whom had acute renal failure (ARF) and continue to require hemodialysis. Two deaths occurred during follow up, both unrelated to the aorta: one with a hemispheric stroke at 6 months and one with respiratory failure at 12 months. Therefore, the overall follow up mortality was 5%. Occlusion of one chimney stent occurred 3 months after the procedure, meaning renal artery patency rate was 98%. The aneurysm diameter reduced from 74 ± 9 mm to 64 ± 10 mm during follow up (p < .05).

CONCLUSION

Ch-EVAR can be used to treat JRAAs with suitable anatomical conditions. However, complications of type I endoleak were not uncommon, and, therefore, further studies are required to prove its efficiency for JRAAs.

摘要

目的

烟囱腔内血管修复术(Ch-EVAR)是治疗肾下型腹主动脉瘤(JRAAs)的一种廉价且即刻可用的方法。本研究旨在报告使用球囊扩张支架(BES)进行 Ch-EVAR 的经验和结果。

方法

2008 年 1 月至 2013 年 6 月(平均时间 26±13 个月),回顾性分析了 42 例接受 Ch-EVAR 的患者。所有患者均被认为有开放手术的高风险,并且不适合(由于经济问题和对延迟的恐惧)进行开窗腔内血管修复术(FEVAR)。

结果

42 例患者(35 例男性;平均年龄 71±7 岁)接受了 56 个肾动脉的烟囱手术,使用了 70 个 BES(59 个 hippocampus 和 11 个 genesis)。中位随访时间为 26 个月(范围 6-64 个月)。主要技术成功率为 100%。30 天死亡率为 0%。完成血管造影显示 8 例(19%)存在 I 型内漏。6 个月的 CT 扫描显示 3 例内漏完全消退,2 例动脉瘤无生长,3 例动脉瘤直径增加小于 10mm。3 例患者在 Ch-EVAR 后发生对比剂诱导的肾病(CIN),其中 2 例发生急性肾衰(ARF)并继续需要血液透析。2 例患者在随访期间死亡,均与主动脉无关:1 例在 6 个月时发生半球性中风,1 例在 12 个月时发生呼吸衰竭。因此,总的随访死亡率为 5%。1 例烟囱支架在术后 3 个月发生闭塞,意味着肾动脉通畅率为 98%。动脉瘤直径在随访期间从 74±9mm 缩小至 64±10mm(p<0.05)。

结论

Ch-EVAR 可用于治疗具有合适解剖条件的 JRAAs。然而,I 型内漏的并发症并不少见,因此需要进一步研究来证明其对 JRAAs 的疗效。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验